Explore
Premium
Sign Up
Log In
CRT 2017 : Late Breaking Trials: Session III
Conference
Add this Moment to your Passport
Learn from this moment and keep it forever.
Add To Passport
$8.99
This moment is included in Simple Premium - Get started for free.
FREE
with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments.
$30.00 per month. Cancel anytime.
Overview
Late Breaking Trials: Session III
Featuring
Nicolas Shammas
Ron Waksman
William Rollefson
Rafael Romaguera
Add this Moment to your Passport
Learn from this moment and keep it forever.
Add To Passport
$8.99
This moment is included in Simple Premium - Get started for free.
FREE
with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments.
$30.00 per month. Cancel anytime.
Moment Components
Late Breaking Trial I: Lutonix® Paclitaxel-coated Balloon To Treat Obstructive Lesions In The Superficial Femoral And Popliteal Arteries: Preliminary Six-month Results From The SAFE-DCB Us Registry - Nicolas Shammas
Late Breaking Trial II: Biofreedom USA: The 12 Months Clinical and 9 Months Angio Results - Ron Waksman
Late Breaking Trial IV: Feasibility And Clinical Importance Of Same Versus Next Day Discharge After Elective Transradial Percutaneous Coronary Intervention, The Rasadda-pci Trial - William Rollefson
Late Breaking Trial III: New Drug-eluting Stents In Patients With Diabetes Mellitus And Multi-Vessel Disease (3d Registry) - Rafael Romaguera
Target Audience
Learning Objectives
Related Moments
CRT 2016 Technology & Innovation - The Best Innovation for CRT 2016
Conference
A session dedicated to the Best Innovation from CRT 2016
CRT 2015 Atherosclerosis & Research - Clinical Trial Organizations
Conference
A session on Clinical Trial Organizations from CRT 2015
Transcatheter Aortic Valve Replacement In Moderate-Risk Aortic Stenosis Patients
Journal
Article on Transcatheter Aortic Valve Replacement In Moderate-Risk Aortic Stenosis Patients
Loading Simple Education